Skip to content
ppharmaranks
Menu
Class IITerminated

Sodium Chloride Injection 9% recall

FDA recall D-0257-2025 · initiated Feb 10, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Mar 19, 2025How we research

Nephron Sterile Compounding Center LLC recalled Sodium Chloride Injection 9% in Feb 2025 — an FDA Class II recall (D-0257-2025) because Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.

Sterility could not be assured

The maker could not guarantee the product was sterile. That matters most for injections and eye products, where a contaminated dose reaches past the body's defences.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot # NA4008B, exp. date 03/03/2025 Lot # NA4005B & NA4005E, exp. date 02/20/2025

Quantity recalled: 4,190 bottles

Details

Product
Sodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing facility, West Columbia, SC 29172, NDC: 69374-334-50
Recalling company
Nephron Sterile Compounding Center LLC
Classification
Class II
Status
Terminated
Type
Voluntary: Firm initiated
Distribution
US Nationwide.
Initiated
Feb 10, 2025
FDA report date
Mar 19, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Sodium Chloride Injection 9% recalled?
Nephron Sterile Compounding Center LLC recalled Sodium Chloride Injection 9% in Feb 2025 — an FDA Class II recall (D-0257-2025) because Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Sodium Chloride Injection 9% recalled?
Per the FDA enforcement record, the reason for recall D-0257-2025 was: Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.
Is a recalled Sodium Chloride Injection 9% dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Sodium Chloride Injection 9% are affected?
Distributed: US Nationwide.. The recall covers these lots — Lot # NA4008B, exp. date 03/03/2025 Lot # NA4005B & NA4005E, exp. date 02/20/2025. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0257-2025.

Source: openFDA Drug Enforcement record D-0257-2025

← All drug recalls